3 HIGH RISK Australian small-caps you need to know

These stocks are small and unprofitable but could result in HUGE paydays for patient investors.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Forget Commonwealth Bank (ASX: CBA), Telstra (ASX: TLS) and Woolworths (ASX: WOW). If you're in the market for high risk/high reward investments, these next 3 businesses could be just what you're looking for. One is already up 100% in 2014 but all are looking likely to grow well into the future.

Admedus (ASX: AHZ) is a junior diversified biotechnology company living in the shadows of great Australian medical success stories like Cochlear (ASX: COH), CSL (ASX: CSL) and Sirtex Medical (ASX: SRX). After falling 10% yesterday, the market has overlooked the increased likelihood of huge revenue growth in the next 5 years because of a very minor capital raising which will be used to drive its overseas sales teams. With a market capitalisation of only $138 million, Admedus presents itself as a high risk but also high reward investment opportunity.

Another bright small-cap is LNG Limited (ASX: LNG). As the name suggests, it's involved in the booming natural gas industry. What makes this such a high risk/high reward investment is its ambitions. It hopes to build an 8 million tonne per annum LNG liquefaction facility in Louisiana, USA. However management have taken strides in reducing the chances of failure and have experience from a previous project. Based on the valuations of similar companies gone before it, the market currently ascribes a value of around $US500 million per 1 million tonnes per annum of LNG throughput. With a market cap of only $240 million if they are successful, the reward for patient investors will be substantial.

Lastly, Yellow Brick Road (ASX: YBR) is a favourite of many growth investors because it is an easy to understand diversified financial company and boasts an experienced management team, led by Wizard Home Loans founder and The Apprentice star, Mark Bouris. YBR's share price has risen strongly in the past month but still has a market capitalisation of only $127 million and remains unprofitable. Its management hope to transform the company into one of Australia's biggest non-bank lenders in coming years via both an organic and acquisitive growth model. Following in the footsteps of companies such as Mortgage Choice (ASX: MOC) and Magellan Financial Group (ASX: MFG), it's got an exciting future ahead.

Motley Fool Contributor Owen Raszkiewicz owns shares in Yellow Brick Road, LNG Limited and Admedus. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »